Florida Cancer Specialists & Research Institute and Humana Sign Multi-Year Agreement

Partnership provides thousands of Humana members in-network access to FCS cancer care

Fort Myers, Fla., September 19, 2019 — Florida Cancer Specialists & Research Institute (FCS) and Humana Inc. (NYSE: HUM) have signed a new multi-year agreement that provides Humana members with in-network access to FCS’ comprehensive range of oncology services.

Beginning October 1, 2019, the agreement adds services at FCS locations throughout the state.  Humana members with coverage provided through Medicare, Medicaid and commercial plans can receive oncology and hematology physician services, as well as radiation oncology, radiology, laboratory, pathology and pharmacy services at in-network rates.


FCS CEO Brad Prechtl, MBA said, “We are so pleased to welcome Humana members.  This agreement means that even more Florida residents can now access FCS providers and services and receive world-class cancer care, as well as treatments for other non-cancer related illnesses, close to where they live and work.”

“This agreement creates future opportunities for FCS and Humana to collaborate and develop value-based programs which will further enhance the quality of patient care and reduce costs,” added FCS President & Managing Physician Dr. Lucio N. Gordan.

“The partnerships we have with our payers, such as Humana, are something we are dedicated to fostering to ensure we can provide long-term solutions that secure cancer care for anyone in need,” said Sarah Cevallos, FCS chief revenue cycle officer. “This partnership demonstrates our mutual commitment to achieve this goal. We are excited to collaborate with Humana and we are looking forward to a long-standing relationship.”


About Florida Cancer Specialists & Research Institute, LLC: (FLCancer.com

Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida. In the past four years, the majority of new cancer drugs approved for use in the U.S. were studied in clinical trials with Florida Cancer Specialists participation.* Trained in such prestigious medical schools and research institutes as Duke, Stanford, Harvard, Emory, M.D. Anderson, and Memorial Sloan Kettering, our physicians are consistently ranked nationally as Top Doctors by U.S. News & World Report.

Founded in 1984, FCS is the largest privately held independent medical oncology/hematology practice in the country. With more than 230 physicians, 220 advanced practice registered nurses (APRN) and physician assistants (PA) and nearly 100 locations in our network, we are committed to providing world-class cancer care in community-based settings, close to home.

Florida Cancer Specialists has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research, cutting-edge technologies and advanced treatments, including targeted therapies, genomic-based treatment, and immunotherapy.  Our highest values are embodied by our outstanding team of highly trained and dedicated physicians, clinicians and staff.

*Prior to approval

For More Information, Contact:
Florida Cancer Specialists & Research Institute
Shelly Glenn, Chief Marketing & Sales Officer
(770) 365.6168

Michelle Robey, Director of Marketing & Communications
(813) 767.9398

About Humana:

Humana Inc. (NYSE: HUM) is committed to helping our millions of medical and specialty members achieve their best health. Our successful history in care delivery and health plan administration is helping us create a new kind of integrated care with the power to improve health and well-being and lower costs. Our efforts are leading to a better quality of life for people with Medicare, families, individuals, military service personnel, and communities at large.

To accomplish that, we support physicians and other health care professionals as they work to deliver the right care in the right place for their patients, our members. Our range of clinical capabilities, resources and tools – such as in-home care, behavioral health, pharmacy services, data analytics and wellness solutions – combine to produce a simplified experience that makes health care easier to navigate and more effective.

More information regarding Humana is available to investors via the Investor Relations page of the company’s web site at www.humana.com, including copies of:

  • Annual reports to stockholders
  • Securities and Exchange Commission filings
  • Most recent investor conference presentations
  • Quarterly earnings news releases and conference calls
  • Calendar of events
  • Corporate Governance information